drugset / Trial / NCT01973205

Efficacy and Safety of Acetaminophen and Aspirin Versus Placebo in the Acute Treatment of Migraine

NCT01973205

Phase 3 Completed 900 enrolled Novartis
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of the study is to evaluate the efficacy and safety of acetaminophen and aspirin versus placebo in the acute treatment of migraine

Timeline

Start
2013-10
Primary completion
2014-07
Completion
2014-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Acetaminophen Small molecule 500 mg
Subject Aspirin Small molecule 500 mg

Indications